Literature DB >> 3002602

Chromosome changes in germ cell tumors of the testis.

Z Gibas, G R Prout, J E Pontes, A A Sandberg.   

Abstract

Chromosome analysis was performed on short-term cultures established from samples of six tumors of the testis. Histologically, four tumors were embryonal cell carcinomas (three primary, one metastatic) and two of mixed histology with predominance of teratoma. The modal chromosome number was hypotriploid in four tumors, triploid in one, and hypertriploid in another. All tumors contained structurally abnormal chromosomes, ranging in number from 1 to 10 in different cases. A small metacentric marker chromosome, identified as an isochromosome of the short arm of chromosome #12 [i(12p)], was present in all tumors analyzed. Unlike other marker chromosomes, this one was invariably present in at least two copies per metaphase in all cases; all other chromosome markers were present in single copy in all tumors. Together with the previous reports on the presence of i(12p) in seminoma and teratoma of the testis, our findings suggest that this karyotypic abnormality is characteristic for all histologic varieties of germ cell tumors of the testis.

Entities:  

Mesh:

Year:  1986        PMID: 3002602     DOI: 10.1016/0165-4608(86)90053-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Bipolar (neural and myoblastic) phenotype in cell lines derived from human germ cell tumours of testis.

Authors:  S Navarro; R Noguera; A Peydró-Olaya; A Llombart-Bosch
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

2.  Demonstration of the genuine iso-12p character of the standard marker chromosome of testicular germ cell tumors and identification of further chromosome 12 aberrations by competitive in situ hybridization.

Authors:  R F Suijkerbuijk; A Y van de Veen; J van Echten; C H Buys; B de Jong; J W Oosterhuis; D A Warburton; J J Cassiman; D Schonk; A Geurts van Kessel
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

3.  Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.

Authors:  W Verbeek; C Bokemeyer; H Falk; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.

Authors:  J J König; E Kamst; A Hagemeijer; J C Romijn; J Horoszewicz; F H Schröder
Journal:  Urol Res       Date:  1989

5.  Loss of heterozygosity in hypotriploid cell cultures from testicular tumours.

Authors:  J M Parrington; L F West; S Povey
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

Review 6.  Small metacentric marker chromosomes, particularly isochromosomes, in cancer.

Authors:  N B Atkin; M C Baker
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

7.  Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors.

Authors:  J Keith Killian; Lambert C J Dorssers; Britton Trabert; Ad J M Gillis; Michael B Cook; Yonghong Wang; Joshua J Waterfall; Holly Stevenson; William I Smith; Natalia Noyes; Parvathy Retnakumar; J Hans Stoop; J Wolter Oosterhuis; Paul S Meltzer; Katherine A McGlynn; Leendert H J Looijenga
Journal:  Genome Res       Date:  2016-10-20       Impact factor: 9.043

8.  A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Charles Lu; Peter Riedell; Christopher A Miller; Ian S Hagemann; Peter Westervelt; Bradley A Ozenberger; Michelle O'Laughlin; Vincent Magrini; Ryan T Demeter; Eric J Duncavage; Malachi Griffith; Obi L Griffith; Lukas D Wartman
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-01

9.  TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.

Authors:  Keiichi Akizuki; Masaaki Sekine; Yasunori Kogure; Takuro Kameda; Kotaro Shide; Junji Koya; Ayako Kamiunten; Yoko Kubuki; Yuki Tahira; Tomonori Hidaka; Takumi Kiwaki; Hiroyuki Tanaka; Yuichiro Sato; Hiroaki Kataoka; Keisuke Kataoka; Kazuya Shimoda
Journal:  BMC Cancer       Date:  2020-01-02       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.